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Bluetongue (BT) is a reportable re-emerging vector-borne disease of animal health 37 
concern. Enzyme-linked immunosorbent assays (ELISA) are frequently used in BT 38 
surveillance programs in domestic ruminants, but their diagnostic accuracy has not been 39 
evaluated for wild ruminants, which can play an important role as natural reservoirs of 40 
bluetongue virus (BTV). The aim of this study was to assess two commercial ELISAs for BT 41 
diagnosis in wild ruminants using control sera of known BTV infection status and field 42 
samples. When control sera were tested, the double recognition ELISA (DR-ELISA) showed 43 
100% sensitivity (Se) and specificity (Sp), while the competitive ELISA (C-ELISA) had 44 
86.4% Se and 97.1% Sp. Using field samples, the selected latent-class analysis model showed 45 
95.7% Se and 85.9% Sp for DR-ELISA, 58.2% Se and 95.8% Sp for C-ELISA and 84.2% Se 46 
for the serum neutralization test (SNT). Our results indicate that the DR-ELISA may be a 47 
useful diagnostic method to assess BTV circulation in endemic areas, while the C-ELISA 48 
should be selected when free-areas are surveyed. The discrepancy between control and field 49 
samples point out that the inclusion of field samples is required to assess the accuracy of 50 
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1. Introduction 59 
Bluetongue (BT) is a re-emergent vector-borne disease affecting domestic and wild 60 
ruminant species. This reportable disease has considerable socioeconomic impact associated 61 
to production losses, costs derived from implementation of control and vaccination programs 62 
and international trade restrictions [1–3]. Bluetongue virus (BTV; genus Orbivirus) is mainly 63 
transmitted between vertebrate hosts by biting midges of the genus Culicoides [4]. Up to date, 64 
27 BTV serotypes have been identified, and since the beginning of the 2000s, a considerable 65 
number of them have been involved in outbreaks in livestock across Europe [5]. Despite 66 
control measures implemented in affected countries, BTV is still circulating in both endemic 67 
and non-endemic regions. Currently, this continent has restricted zones for BTV serotypes 1, 68 
2, 3, 4, 8 and 16 [6].  69 
BT surveillance in livestock is usually conducted by using serological methods. 70 
Among them, serum neutralization test (SNT) is considered a highly specific technique [7,8] 71 
which has been used as reference technique for testing other serological methods [9] and 72 
allows the serotype identification [10]. However, SNT sensitivity (Se) is estimated to be less 73 
than perfect [8]. Moreover, it is complex, expensive, time-consuming and sensitive to the 74 
quality of the sample. In contrast, enzyme-linked immunosorbent assays (ELISAs) are quick, 75 
easy to use, have a relatively low cost and allow the detection of all serotypes since they use 76 
the conserved viral protein 7 (VP7) as antigen [11]. For these reasons, ELISA methods are 77 
endorsed by the OIE [10] and are frequently used in BT surveillance programs in livestock.  78 
Wild ruminants are susceptible to BTV infection and their potential role as natural 79 
reservoir has been evidenced [12–15]. The epizootic cycle of BTV among wild ruminants and 80 
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competent vectors is considered an important factor in the maintenance of the virus in certain 81 
regions [16], being of particular interest in areas where these species coexist with livestock 82 
[15]. BTV circulation in wild ruminants, especially when high densities occur, make them 83 
useful as sentinels [17], particularly in areas where vaccination programs have been 84 
implemented in livestock.  85 
Different commercial ELISAs have been used to detect anti-BTV antibodies in wild 86 
ruminants in previous studies [15,18–20]. However, the success of surveillance in these 87 
species can be compromised by the accuracy of the diagnostic techniques employed. 88 
Diagnostic validity of ELISA methods for the detection of antibodies against BTV have been 89 
evaluated in livestock in numerous studies [21], but rarely in wild ruminants [8,22]. Hence, 90 
we investigate the accuracy of two commercial ELISAs, namely double recognition ELISA 91 
(DR-ELISA) and competitive ELISA (C-ELISA), for the diagnosis of BTV in wild ruminant 92 
species. The aims of the study were (1) to compare the diagnostic accuracy of DR-ELISA and 93 
C-ELISA using control sera from wild ruminants of known BTV infection status, and (2) to 94 
test the performance of both ELISAs and SNT, using serum samples from wild ruminants of 95 
unknown infection status collected under field conditions. 96 
2. Materials and methods 97 
2.1. Control samples  98 
A total of 57 sera of known BTV infection status were used as control samples. 99 
Positive control sera were obtained from 14 Spanish ibex (Capra pyrenaica hispanica) and 100 
eight red deer (Cervus elaphus) from two experimental studies (for further details, see 101 
[23,24]). Negative controls (19 red deer and 16 Spanish ibex) used in the same previous 102 
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studies were also included and they came from BTV-free areas in which outbreaks have not 103 
been reported. Both positive and negative controls were verified by SNT and real-time reverse 104 
transcription polymerase chain reaction [23,24]. 105 
2.2. Field samples 106 
A total of 264 free-ranging wild ruminants including 171 red deer, 58 fallow deer 107 
(Dama dama) and 35 European mouflon (Ovis aries musimon), were sampled in Southern 108 
Spain (36ºN to 38º60´N, 1º75´W to 7º25´W) between the hunting seasons 2007/2008 and 109 
2014/2015. Samples were obtained in a region and time period with a wide circulation of 110 
BTV in livestock (RASVE 2019). Blood samples were taken by puncture of the endocranial 111 
venous sinuses, as previously described [26]. Samples were placed into sterile tubes without 112 
anticoagulant and centrifuged at 400 g for 15 minutes. Sera were stored at -20 ºC until 113 
analyses.  114 
2.3. Serological tests 115 
All sera were tested using two commercial ELISA kits: DR-ELISA (INGEZIM BTV 116 
DR 12.BTV.K0, INGENASA, Spain) and C-ELISA (ID Screen Bluetongue Competition 117 
ELISA kit, IDVET, France). Both ELISAs were performed following the manufacturers’ 118 
instructions. Sensitivity (Se) and specificity (Sp) values provided by the manufacturers were 119 
100% and 97.3% for DR-ELISA and 100% and 100% for C-ELISA, respectively. The cut-off 120 
of positive readings was calculated according the instructions of each test:  121 
DR-ELISA: Positive sample = optical density (OD) sample > 0.15 x OD positive 122 
control 123 
C-ELISA: Positive sample = OD sample / OD negative control x 100 > 40% 124 
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With the aim of evaluating the repeatability of the assay, the same positive and 125 
negative controls were included in duplicate in every plate of the study (which were tested on 126 
the same day and on different days, as well as by different operators). Additionally, field 127 
samples were tested by SNT for the detection of antibodies against BTV-1, BTV-4 and BTV-128 
8 serotypes, which are the serotypes that have been circulating in the sampling area in the last 129 
two decades [25]. The SNT protocol was performed as previously described [10]. Briefly, 130 
serum samples were inactivated at 56°C for 30 minutes prior to analysis. Sera were diluted 131 
(1:2-1:256) in MEM (Eagle’s minimum essential medium) and mixed with 100 TCID50 (50% 132 
tissue culture infective doses) of each reference strain, BTV-1, BTV-4 and BTV-8. Plates 133 
were incubated for 1 hour 30 minutes at 37°C. Finally, 100 μL of a Vero E6 cells suspension 134 
(1.5 × 104 cells/well) were added in cell growth media (MEM supplemented with 15% foetal 135 
calf serum, 300 μg L-glutamine/mL, 300 U penicillin/mL and 300 μg streptomycin/mL). The 136 
mixture was further incubated for 6-7 days at 37ºC until a cytopathic effect (CPE) was 137 
developed in control wells containing 100 TCID50 of virus and no serum. Only samples that 138 
showed neutralization (absence of CPE) at dilutions ≥ 1:4 were considered positive [24]. 139 
Controls for cytotoxicity in the absence of virus were included for each analysis at a dilution 140 
of 1:2.  141 
2.4. Statistical analysis 142 
For both ELISAs, Se and Sp values were calculated from control sera. The package 143 
“OptimalCutpoints” of the statistical software R [27] was used to obtain Se and Sp with 95% 144 
confidence intervals (CI 95%), differential positive and negative rates, and the area under the 145 
curve (AUC) determined by receiver operating characteristic analysis [28]. AUC was 146 
calculated just for obtaining a single numerical estimate of the overall accuracy of the ELISAs 147 
using the control sera. The agreement between ELISA tests was measured by the kappa index 148 
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(κ) using the R package “epiR” and differences between methods were analysed by the 149 
McNemar’s test for correlated proportions in subgroups of positive and negative animals, 150 
respectively. 151 
The overall agreement and the kappa index of both ELISAs and SNT were also 152 
calculated from the field samples. These sera were also used to estimate the Se and Sp of 153 
ELISAs and SNT by latent class analysis (LCA) considering three tests and one population. 154 
The scripts used for the analysis were described previously [29]. A conditional independence 155 
(CID) assumption was initially considered for LCA models. However, since the compared 156 
tests are based in the detection of the same biological property, implications of conditional 157 
dependence (CD) were also explored by running separate models that accounted for model 158 
co-variance, which was calculated and implemented as described previously [30]. The prior 159 
information for the ELISA parameters was obtained from the results of control sera. For SNT 160 
Se, prior information was estimated from previous results in the literature [8] (mean = 90%; 161 
85% sure > 85%) assuming a beta distribution (62,7). SNT Sp was assumed to be 100% based 162 
on the assumption that the test is highly specific and showed perfect specificity in previous 163 
studies with wild ruminants [8]. In addition, CID and CD models with vague priors were also 164 
run to explore the impact of changing priors. The models were compared and selected 165 
considering the Deviance Information Criterion (DIC) [31]. For each model, three chains 166 
were run simultaneously from different initial starting points. A total of 120,000 iterations 167 
were used with a burn-in of 10,000 iterations and a thinning of five. Mean values and 95% 168 
posterior credibility intervals (PCI) were extracted from the posterior distribution of the 169 
different parameters of the model. Models were fitted with the software JAGS version 2.2.0 170 
(http://mcmc-jags.sourceforge.net/). Convergence was assessed by visual inspection of the 171 
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trace plots of the sampled parameters and autocorrelation plots, and with the Geweke 172 
diagnostic [32] and the Heidelberger and Welch diagnostic [33] using the R package “coda”.  173 
3. Results 174 
3.1. Control samples 175 
Results of Se and Sp for ELISAs using the control sera are shown in Table 1. DR-176 
ELISA showed a 100% of Se and Sp, while C-ELISA showed Se = 86.4% and Sp = 97.1%. 177 
No statistical differences were found between both ELISAs, neither in the subpopulation of 178 
positives (p = 0.248) nor in the subpopulation of negative sera (p = 0.999) and the tests 179 
presented a very good concordance with a high kappa index (κ = 0.85; CI 95%: 0.71-0.99).  180 
3.2. Field samples 181 
Of the 264 field sera, 198 showed positive results to the DR-ELISA (75.0%), 108 to 182 
the C-ELISA (40.9%) and 157 to SNT (59.5%). Results between ELISAs showed a fair 183 
agreement, with κ = 0.31 (CI 95%: 0.22-0.39). The DR-ELISA detected the highest number of 184 
positives samples, including a high percentage of sera that tested negative to other techniques 185 
(44.9% to SNT, 60.9% to C-ELISA). On the contrary, the C-ELISA detected the highest 186 
number of negatives samples including a high percentage of sera that tested positive to other 187 
methods (60.9% to DR-ELISA and 42.7% to SNT) (Table 2).  188 
The LCA model that showed the best performance and DIC values was the 189 
informative CID model. When CD was considered, the models showed less convergence and 190 
higher levels of correlation than when CID was assumed, with and without informative priors. 191 
Estimates from CD models presented larger PCI that overlapped with CID models. Estimates 192 
of Se and Sp derived from the selected CID model are shown in Table 3. The informative CID 193 
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model showed a high Se (95.7%; PCI 95%: 92.4-98.1%) but moderate Sp (85.9%; PCI 95%: 194 
73.6-98.4%) for the DR-ELISA. In contrast, the C-ELISA had very low Se (58.2%; PCI 95%: 195 
50.7-65.7%), but Sp was high (95.8%; PCI 95%: 90.8-99.1%). SNT Se was 84.2% (PCI 95%: 196 
77.5-90.2%).  197 
4. Discussion 198 
 Wild ruminants have been proposed as and suitable sentinel species for monitoring 199 
BTV, particularly in regions where livestock are vaccinated [17]. The importance to include 200 
these potential wild reservoirs in BT surveillance programs highlights the need of validated 201 
serological methods for every epidemiological context. Despite the performance of 202 
commercial ELISAs for detection of anti-BTV antibodies has been evaluated in livestock in 203 
different studies [21], to the author’s knowledge, the accuracy of these techniques has not 204 
been assessed in wild ruminant species. In the present study, we have assessed two 205 
commercial ELISAs using control and field sera from wild ruminants. Both DR-ELISA and 206 
C-ELISA showed high Se and Sp values and a strong concordance between them when 207 
control sera were tested. These findings are in accordance with those previously obtained in 208 
domestic ruminants with a known BTV infection status using the same commercial ELISA 209 
tests [34,35]. Similarly, experimental studies on challenged ruminant and camelid species 210 
showed an overall good performance of both ELISAs [36–38]. 211 
When field samples were analysed, results between ELISAs presented poor 212 
agreement. Interestingly, the discrepancies of both ELISAs have an opposite nature when they 213 
were compared to SNT. DR-ELISA presented the highest number of positive sera, but with a 214 
high proportion of samples testing negative to SNT (44.9%). Similar findings were obtained 215 
in previous serosurvey studies in wild ruminant species using the same tests [19,24]. The 216 
differentiated ability to detect recent infections [36–38], the targeting of the different antibody 217 
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populations [39], cytotoxicity reactions of sera with low titres of specific neutralizing 218 
antibodies or the circulation of serotypes not included in the SNT are possible factors 219 
implicated in the discrepancies observed. On the other hand, a high number of negative sera 220 
by C-ELISA showed positive results by SNT (42.7%). Since SNT is considered a very high 221 
specific technique [7,8], this finding suggests false negative results by C-ELISA. Further 222 
investigations are required to determine the precise nature of the discrepancies found among 223 
the three analysed serological methods. 224 
The differences observed between control and field samples point out how field 225 
conditions can affect the accuracy of the diagnostic methods. In the control group, samples 226 
are usually collected from live captive individuals, while samplings in free-ranging animals 227 
present difficulties that may lead to poor sera quality, which subsequently may affect the 228 
performance of the diagnostic tests [19,40]. Blood collection in wild ruminants is frequently 229 
performed in hunted-harvested animals and sera are frequently taken hours after death. 230 
Moreover, the sampling method used in these species has been showed to have influence in 231 
the quality of samples [26]. In this regard, haemolytic sera affect SNT performance due to the 232 
presence of cytotoxicity and cloudy suspensions that may influence the final outcome [15,19]. 233 
In the same way, when repeated freeze-thawing cycles are applied to haemolytic sera, the 234 
ELISA performance may also be affected [40]. Our results indicate that, in order to have a 235 
better estimation of the diagnostic tests performance, these methods should be evaluated 236 
including not only control sera but also field samples.  237 
The LCA model showed a lower accuracy of both ELISAs compared to the results 238 
when control sera were evaluated. The results also differed with those indicated by the 239 
manufacturers and with those reported in livestock under field conditions. In domestic 240 
ruminant species, Se values ranged from 98.2 to 100% and reached 99.5% Sp for DR-ELISA, 241 
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while Se and Sp values for C-ELISA ranged from 87.8 to 100% and from 98.2% to 99.3%, 242 
respectively [34,35,41]. In addition, the LCA also showed marked differences between 243 
ELISAs. DR-ELISA showed a high Se, even higher to SNT, but Sp was moderated, while the 244 
C-ELISA showed low Se and high Sp. These results indicate that commercial ELISAs can be 245 
used for BTV surveillance in wild ruminants with appropriate considerations. In absence of a 246 
gold-standard method for detection of antibodies against BTV, the serological test with 247 
highest Se is preferred in endemic areas to reveal the exposure to the virus. In this context, the 248 
DR-ELISA should be selected, though a subsequent verification of the DR-ELISA positive 249 
samples using other methods such as SNT may be contemplated to ensure the results. In 250 
contrast, the C-ELISA is less suitable for BTV monitoring in endemic areas, since it could 251 
largely underestimate the number of infected animals. Nevertheless, when free-areas are 252 
assessed, the test with highest Sp must be used to avoid false positive results that lead to an 253 
incorrect sanitary classification of the area. In this epidemiological scenario, the C-ELISA 254 
should be preferably selected as diagnostic method. 255 
In conclusion, the results obtained in the present study indicate that the accuracy of 256 
commercial ELISA methods for diagnosis of BTV in wild ruminants requires of a particular 257 
approach and it cannot be inferred straightforwardly from their performance in livestock. 258 
When control sera were analysed, both ELISAs showed a good diagnostic validity, 259 
comparable to their performance in domestic ruminants. However, in field conditions, the Se 260 
and Sp differed, which indicates that their use should be evaluated according to the 261 
epidemiological scenario. In this regard, the DR-ELISA may be a useful method to assess 262 
BTV circulation in endemic areas, while the C-ELISA Sp should be selected when free-areas 263 
are surveyed. The discrepancy between control and field samples reveals that control sera are 264 
not enough to know the performance of an ELISA and the inclusion of field samples should 265 
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be taken into account when the diagnostic validity is assessed. Further investigations 266 
including the analysis of different wild ruminant or camelid species, age classes or different 267 
immunological status are warranted to optimize the accuracy of the parameters obtained in 268 
this study.  269 
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Table 1. Accuracy of two commercial ELISAs (DR-ELISA and C-ELISA) by testing 402 
control sera samples. 403 
Parameter DR-ELISA C-ELISA 
Se (CI 95%) (n = 22) 100 (97.3-100) 86.4 (69.8-100) 
Sp (CI 95%) (n = 35) 100 (98.6-100) 97.1 (90.2-100) 
DPR (CI 95%) - 30.2 (4.3-210.1) 
DNR (CI 95%) - 0.1 (0.05-0.4) 
AUC (CI 95%) 1 0.918 (0.839-0.996) 
DR-ELISA, double recognition ELISA; C-ELISA, competitive ELISA; Se, sensitivity; 404 
Sp, specificity; DPR, differential positive rate, DNR: differential negative rate, AUC: 405 
area under the curve 406 
 407 



























 103 (95.4) 95 (60.9) 
0.62 
0.31 
(0.22-0.39) Negative (%) 7 (4.5) 59 (55.1)  5 (4.6) 61 (39.1) 
C-ELISA 




 - - - - 
Negative (%) 67 (42.7) 89 (83.2)  - - - - 
DR-ELISA, double recognition ELISA; C-ELISA, competitive ELISA; SNT, serum neutralization test; CI, confidence interval 
 
Table 3. Results of the model (informative, conditionally independent) for DR-ELISA, 410 
C- ELISA and SNT when assessing field sera (n = 264). 411 
Variable Mean PCI 95% Priors 
DR-ELISA Se 95.7% 92.4-98.1 beta[23,1] 
C-ELISA Se 58.2% 50.7-65.7 beta[20,4] 
SNT Se 84.2% 77.5-90.2 beta[62,7] 
DR-ELISA Sp 85.9% 73.6-98.4 beta[36,1] 
C-ELISA Sp 95.8% 90.8-99.1 beta[35,2] 
SNT Sp 100% 100% a 
DIC 872.984   
a Assumed to be 100% 412 
DR-ELISA, double recognition ELISA; C-ELISA, competitive ELISA; SNT, serum 413 
neutralization test; PCI, posterior credibility intervals; Se, sensitivity; Sp, specificity; 414 
DIC, deviance information criterion  415 
 416 
 417 
